Browse by UCL people
Group by: Type | Date
Number of items: 275.
Article
Abeysekera, Kushala WM;
Valenti, Luca;
Younossi, Zobair;
Dillon, John F;
Allen, Alina M;
Nourredin, Mazen;
Rinella, Mary E;
... Tsochatzis, Emmanuel A; + view all
(2024)
Implementation of a liver health check in people with type 2 diabetes.
The Lancet Gastroenterology & Hepatology
, 9
(1)
pp. 83-91.
10.1016/S2468-1253(23)00270-4.
|
|
Adams, Leon A;
Thiele, Maja;
Tsochatzis, Emmanouil A;
(2025)
Detecting at-risk steatotic liver disease and liver fibrosis in the community.
Hepatology
10.1097/HEP.0000000000001400.
(In press).
|
|
Allen, Alina M;
Younossi, Zobair M;
Tsochatzis, Emmanuel A;
Alazawi, William;
Zelber-Sagi, Shira;
Arab, Juan Pablo;
Cusi, Kenneth;
(2023)
Measuring NAFLD models of care.
Nature Reviews Gastroenterology and Hepatology
, 20
pp. 626-627.
10.1038/s41575-023-00798-9.
|
|
Allen, AM;
Lazarus, JV;
Alkhouri, N;
Noureddin, M;
Wong, VWS;
Tsochatzis, EA;
de Avila, L;
... Younossi, ZM; + view all
(2025)
Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction–associated steatotic liver disease.
Hepatology Communications
, 9
(5)
, Article e0678. 10.1097/HC9.0000000000000678.
|
 |
|
Assimakopoulos, Stelios F;
Bhagani, Sanjay;
Aggeletopoulou, Ioanna;
Tsounis, Efthymios P;
Tsochatzis, Emmanuel A;
(2024)
The role of gut barrier dysfunction in postoperative complications in liver transplantation: pathophysiological and therapeutic considerations.
Infection
10.1007/s15010-024-02182-4.
(In press).
|
|
Augustin, S;
Ahmed, A;
Alkhouri, N;
Canbay, A;
Corless, L;
Nakajima, A;
Okanoue, T;
... Romero-Gómez, M; + view all
(2020)
Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice.
Journal of Gastrointestinal and Liver Diseases
, 29
(2)
pp. 235-245.
10.15403/jgld-775.
|
 |
|
Augustin, S;
Pons, M;
Maurice, JB;
Bureau, C;
Stefanescu, H;
Ney, M;
Blasco, H;
... Genescà, J; + view all
(2017)
Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
Hepatology
, 66
(6)
pp. 1980-1988.
10.1002/hep.29363.
|
|
Aziz, Bishoi;
Kok, Beverley;
Cheah, Matthew;
Lytvyak, Ellina;
Moctezuma-Velazquez, Carlos;
Wasilenko, Shawn;
Tsochatzis, Emmanuel;
... Mason, Andrew L; + view all
(2025)
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.
The American Journal of Gastroenterology
, 120
(2)
pp. 459-468.
10.14309/ajg.0000000000002977.
|
|
|
Bañares, Juan;
Pons, Mònica;
Reiberger, Thomas;
Mandorfer, Mattias;
Jachs, Mathias;
Semmler, Georg;
Colecchia, Antonio;
... a study by the Baveno Cooperation: an EASL consortium; + view all
(2025)
Refining the Baveno VII criteria for clinically significant portal hypertension: an individual-patient data meta-analysis.
Journal of Hepatology
10.1016/j.jhep.2025.10.014.
(In press).
|
|
Benmassaoud, A;
Roccarina, D;
Arico, F;
Leandro, G;
Yu, B;
Cheng, F;
Yu, D;
... Tsochatzis, E; + view all
(2020)
Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
The American Journal of Gastroenterology
, 115
(11)
pp. 1911-1914.
10.14309/ajg.0000000000000959.
|
|
Benmassaoud, A;
Tsochatzis, E;
(2021)
Response to Anand and Sharma.
The American Journal of Gastroenterology
, 116
(5)
pp. 1094-1095.
10.14309/ajg.0000000000001108.
|
|
Benmassaoud, Amine;
Macias, Juan;
Delamarre, Adèle;
Corma-Gomez, Anaïs;
Guaraldi, Giovanni;
Milic, Jovana;
Rockstroh, Jürgen K;
... Sebastiani, Giada; + view all
(2023)
Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.
Liver International
10.1111/liv.15605.
(In press).
|
|
|
Benmassaoud, Amine;
Roccarina, Davide;
Arico, Francesco Marcello;
Marta, Cilla;
Donghia, Rossella;
Leandro, Gioacchino;
Prat, Laura Iogna;
... Tsochatzis, Emmanuel A; + view all
(2023)
Sex is a major effect modifier between body composition and mortality in patients with cirrhosis assessed for liver transplantation.
Liver International
, 43
(1)
pp. 160-169.
10.1111/liv.15293.
|
|
Benmassaoud, A;
Freeman, SC;
Roccarina, D;
Plaz Torres, MC;
Sutton, AJ;
Cooper, NJ;
Iogna Prat, L;
... Gurusamy, KS; + view all
(2020)
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 1
, Article CD013123. 10.1002/14651858.CD013123.pub2.
|
|
Benmassaoud, A;
Tsochatzis, EA;
(2018)
Loco-regional treatments on the liver transplant waiting list: unmasking hepatocellular carcinoma (HCC) biology.
[Editorial comment].
Hepatobiliary Surgery and Nutrition
, 7
(3)
pp. 199-201.
10.21037/hbsn.2018.02.03.
|
|
Bertino, G;
Privitera, G;
Purrello, F;
Demma, S;
Crisafulli, E;
Spadaro, L;
Koukias, N;
(2016)
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
Internal and Emergency Medicine
, 11
(7)
pp. 905-916.
10.1007/s11739-016-1478-7.
|
|
|
Berzigotti, A;
Tsochatzis, E;
Boursier, J;
Castera, L;
Cazzagon, N;
Friedrich-Rust, M;
Petta, S;
(2022)
Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update".
Journal of Hepatology
, 76
(1)
pp. 251-252.
10.1016/j.jhep.2021.10.008.
|
|
Best, LM;
Freeman, SC;
Sutton, AJ;
Cooper, NJ;
Tng, E-L;
Csenar, M;
Hawkins, N;
... Gurusamy, KS; + view all
(2019)
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 2019
(9)
, Article CD013103. 10.1002/14651858.CD013103.pub2.
|
|
Best, LM;
Leung, J;
Freeman, SC;
Sutton, AJ;
Cooper, NJ;
Milne, EJ;
Cowlin, M;
... Gurusamy, KS; + view all
(2020)
Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 1
, Article CD013203. 10.1002/14651858.CD013203.pub2.
|
|
Best, LMJ;
Freeman, S;
Sutton, AJ;
Hawkins, N;
Tsochatzis, E;
Gurusamy, KS;
(2018)
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: A network meta-analysis.
Cochrane Database of Systematic Reviews
, 2018
(9)
10.1002/14651858.CD013103.
|
|
Beumer, Berend R;
van Vugt, Jeroen LA;
Sapisochin, Gonzalo;
Yoon, Peter;
Bongini, Marco;
Lu, Di;
Xu, Xiao;
... IJzermans, Jan NM; + view all
(2022)
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria.
Journal of Cachexia, Sarcopenia and Muscle
10.1002/jcsm.13053.
(In press).
|
|
Böttcher, K;
rombouts, K;
Saffioti, F;
Roccarina, D;
Rosselli, M;
Hall, A;
Luong, T;
... Pinzani, M; + view all
(2018)
MAIT cells are chronically activated in patients with autoimmune liver disease and promote pro-fibrogenic hepatic stellate cell activation.
Hepatology
, 68
(1)
pp. 172-186.
10.1002/hep.29782.
|
|
Boursier, J;
Roux, M;
Costentin, C;
Chaigneau, J;
Fournier-Poizat, C;
Trylesinski, A;
Canivet, CM;
... Newsome, PN; + view all
(2023)
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
Nature Communications
, 14
(1)
, Article 5219. 10.1038/s41467-023-40328-4.
|
|
Boursier, J;
Tsochatzis, EA;
(2021)
Case-finding strategies in non-alcoholic fatty liver disease.
JHEP Reports
, 3
(2)
, Article 100219. 10.1016/j.jhepr.2020.100219.
|
|
|
Brennan, Paul N;
Tavabie, Oliver D;
Li, Wenhao;
Marjot, Thomas;
Corless, Lynsey;
Fallowfield, Jonathan A;
Jarvis, Helen;
... Abeysekera, Kushala WM; + view all
(2024)
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.
The Lancet Gastroenterology & Hepatology
, 9
(6)
pp. 577-582.
10.1016/S2468-1253(23)00453-3.
|
|
Bricogne, Christopher;
Halliday, Neil;
Fernando, Raymond;
Tsochatzis, Emmanuel A;
Davidson, Brian R;
Harber, Mark;
Westbrook, Rachel H;
(2022)
Donor-recipient HLA-A mismatching is associated with hepatic artery thrombosis, sepsis, graft loss and reduced survival after liver transplantation.
Liver Transplantation
, 28
(8)
pp. 1306-1320.
10.1002/lt.26458.
|
|
Bryce, K;
Tsochatzis, EA;
(2017)
Downstaging for hepatocellular cancer: Harm or benefit?
Translational Gastroenterology and Hepatology
, 2
, Article 106. 10.21037/tgh.2017.11.18.
|
|
Buzzetti, E;
Linden, A;
Best, LM;
Madden, AM;
Roberts, D;
Chase, TJG;
Freeman, SC;
... Gurusamy, KS; + view all
(2021)
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 6
, Article CD013156. 10.1002/14651858.CD013156.pub2.
|
|
Buzzetti, E;
Hall, A;
Ekstedt, M;
Manuguerra, R;
Guerrero Misas, M;
Covelli, C;
Leandro, G;
... Tsochatzis, EA; + view all
(2019)
Collagen proportionate area is an independent predictor of long‐term outcome in patients with non‐alcoholic fatty liver disease.
Alimentary Pharmacology and Therapeutics
, 49
(9)
pp. 1214-1222.
10.1111/apt.15219.
|
|
Buzzetti, E;
Kalafateli, M;
Thorburn, D;
Davidson, BR;
Thiele, M;
Gluud, LL;
Del Giovane, C;
... Gurusamy, KS; + view all
(2017)
Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis.
Cochrane Database of Systematic Reviews
, 3
, Article CD011646. 10.1002/14651858.CD011646.pub2.
|
|
Buzzetti, E;
Kalafateli, M;
Thorburn, D;
Davidson, BR;
Tsochatzis, E;
Gurusamy, KS;
(2017)
Interventions for hereditary haemochromatosis: an attempted network meta-analysis.
Cochrane Database Syst Rev
, 3
, Article CD011647. 10.1002/14651858.CD011647.pub2.
|
|
Buzzetti, E;
Parikh, PM;
Gerussi, A;
Tsochatzis, E;
(2017)
Gender differences in liver disease and the drug-dose gender gap.
Pharmacological Research
, 120
pp. 97-108.
10.1016/j.phrs.2017.03.014.
|
|
Buzzetti, E;
Petta, S;
Manuguerra, R;
Luong, TV;
Cabibi, D;
Corradini, E;
Craxì, A;
... Pietrangelo, A; + view all
(2019)
Evaluating the association of serum ferritin and hepatic iron with disease severity in non‐alcoholic fatty liver disease.
Liver International
, 39
(7)
pp. 1325-1334.
10.1111/liv.14096.
|
|
Buzzetti, E;
Pinzani, M;
Tsochatzis, EA;
(2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Metabolism
, 65
(8)
pp. 1038-1048.
10.1016/j.metabol.2015.12.012.
|
|
Buzzetti, E;
Tsochatzis, EA;
(2019)
Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes non‐alcoholic fatty liver disease—authors' reply.
Alimentary Pharmacology & Therapeutics
, 50
(3)
p. 339.
10.1111/apt.15385.
|
|
Buzzetti, E;
Tsochatzis, EA;
(2019)
Editorial: collagen proportionate area as a prognostic indicator in NAFLD—authors’ reply.
[Editorial comment].
Alimentary Pharmacology & Therapeutics
, 49
(11)
pp. 1454-1455.
10.1111/apt.15271.
|
|
Castera, L;
Rinella, ME;
Tsochatzis, EA;
(2025)
Noninvasive Assessment of Liver Fibrosis.
New England Journal of Medicine
, 393
(17)
pp. 1715-1729.
10.1056/NEJMra2403308.
|
|
Cattazzo, Filippo;
Lombardi, Rosa;
Mantovani, Anna;
Bevilacqua, Michele;
Zoncape, Mirko;
Prat, Laura Iogna;
Roccarina, Davide;
... Dalbeni, Andrea; + view all
(2022)
Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension.
Nutrition Metabolism and Cardiovascular Diseases
, 32
(12)
pp. 2839-2847.
10.1016/j.numecd.2022.08.005.
|
|
Cheuk-Fung Yip, Terry;
Lee, Hye Won;
Lin, Huapeng;
Tsochatzis, Emmanuel;
Petta, Salvatore;
Bugianesi, Elisabetta;
Yoneda, Masato;
... Wai-Sun Wong, Vincent; + view all
(2025)
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease.
Journal of Hepatology
10.1016/j.jhep.2025.01.014.
|
|
Chun, Ho Soo;
Lee, Minjong;
Lee, Hye Ah;
Park, Eun Seo;
Choi, Jeong Yoon;
Baek, Hyo Song;
Kim, Tae Hun;
... Kim, Seung Up; + view all
(2025)
A novel risk prediction model for hepatocellular carcinoma in MASLD: A multinational, multicenter cohort study.
Clin Gastroenterol Hepatol
10.1016/j.cgh.2025.06.025.
(In press).
|
|
Crossan, C;
Majumdar, A;
Srivastava, A;
Thorburn, D;
Rosenberg, W;
Pinzani, M;
Longworth, L;
(2019)
Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: diagnostic accuracy and cost analysis.
Liver International
, 39
(11)
pp. 2052-2060.
10.1111/liv.14198.
|
|
Crossan, C;
Tsochatzis, EA;
Longworth, L;
Gurusamy, K;
Papastergiou, V;
Thalassinos, E;
Mantzoukis, K;
... Burroughs, AK; + view all
(2016)
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation.
Journal of Viral Hepatology
, 23
(2)
pp. 139-149.
10.1111/jvh.12469.
|
|
Cullis, JO;
Fitzsimons, EJ;
Griffiths, WJH;
Tsochatzis, E;
Thomas, DW;
(2018)
Investigation and management of a raised serum ferritin.
British Journal of Haematology
, 181
(3)
pp. 331-340.
10.1111/bjh.15166.
|
|
D'Amico, Gennaro;
Zipprich, Alexander;
Villanueva, Candid;
Sorda, Juan Antonio;
Morillas, Rosa Maria;
Garcovich, Matteo;
Garcia Retortillo, Montserrat;
... Garcia-Tsao, Guadalupe; + view all
(2024)
Further decompensation in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements.
Hepatology
, 79
(4)
pp. 869-881.
10.1097/HEP.0000000000000652.
|
|
Dalbeni, A;
Garbin, M;
Zoncapè, M;
Romeo, S;
Cattazzo, F;
Mantovani, A;
Cespiati, A;
... Lombardi, R; + view all
(2023)
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population.
International Journal of Molecular Sciences
, 24
(21)
, Article 15837. 10.3390/ijms242115837.
|
|
de Franchis, R;
Bosch, J;
Garcia-Tsao, G;
Reiberger, T;
Ripoll, C;
Abraldes, JG;
Albillos, A;
... Yoshiji, H; + view all
(2022)
Baveno VII – Renewing consensus in portal hypertension.
Journal of Hepatology
, 76
(4)
pp. 959-974.
10.1016/j.jhep.2021.12.022.
|
|
De Luca, Laura;
Westbrook, Rachel;
Tsochatzis, Emmanuel A;
(2015)
Metabolic and cardiovascular complications in the liver transplant recipient.
Annals of Gastroenterology
, 28
(2)
182 - 192.
|
|
|
De Luca, L;
Kalafateli, M;
Bianchi, S;
Alasaker, N;
Buzzetti, E;
Rodríguez-Perálvarez, M;
Thorburn, D;
... Tsochatzis, EA; + view all
(2019)
Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors.
Liver International
, 39
(8)
pp. 1557-1565.
10.1111/liv.14185.
|
|
Dionigi, E;
Garcovich, M;
Borzio, M;
Leandro, G;
Majumdar, A;
Tsami, A;
Arvaniti, V;
... Tsochatzis, EA; + view all
(2017)
Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity.
American Journal of Gastroenterology
, 112
(4)
pp. 588-596.
10.1038/ajg.2017.19.
|
|
Eddowes, PJ;
Sasso, M;
Allison, M;
Tsochatzis, E;
Anstee, QM;
Sheridan, D;
Guha, IN;
... Newsome, PN; + view all
(2019)
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Gastroenterology
, 156
(6)
pp. 1717-1730.
10.1053/j.gastro.2019.01.042.
|
|
European Association for the Study of the Liver;
Berzigotti, A;
Tsochatzis, E;
Boursier, J;
Castera, L;
Cazzagon, N;
Friedrich-Rust, M;
... Thiele, M; + view all
(2021)
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update.
Journal of Hepatology
, 75
(3)
pp. 659-689.
10.1016/j.jhep.2021.05.025.
|
|
Farahat, Taghreed M;
Ungan, Mehmet;
Vilaseca, Josep;
Ponzo, Jacqueline;
Prasad Gupta, Pramendra;
Schreiner, Andrew D;
Al Sharief, Wadeia;
... Cortez-Pinto, Helena; + view all
(2022)
The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint.
Liver International
, 42
(6)
pp. 1259-1267.
10.1111/liv.15188.
|
|
Fatourou, EM;
Tsochatzis, EA;
(2019)
Management of metabolic syndrome and cardiovascular risk after liver transplantation.
The Lancet Gastroenterology and Hepatology
, 4
(9)
pp. 731-741.
10.1016/S2468-1253(19)30181-5.
|
|
Fatourou, EM;
Tsochatzis, EA;
(2016)
Transfusion strategies in patients with cirrhosis: Less is more.
Liver International
, 36
(4)
pp. 503-504.
10.1111/liv.13056.
|
|
Feng, G;
Mózes, FE;
Ji, D;
Treeprasertsuk, S;
Okanoue, T;
Shima, T;
Liang, H;
... Zheng, MH; + view all
(2025)
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study.
Clinical Gastroenterology and Hepatology
, 23
(5)
pp. 785-796.
10.1016/j.cgh.2024.07.045.
|
|
Firl, DJ;
Sasaki, K;
Agopian, VG;
Gorgen, A;
Kimura, S;
Dumronggittigule, W;
McVey, JC;
... Aucejo, FN; + view all
(2020)
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.
Hepatology
, 71
(2)
pp. 569-582.
10.1002/hep.30838.
|
|
Fitzsimons, EJ;
Cullis, JO;
Thomas, DW;
Tsochatzis, E;
Griffiths, WJH;
British Society for Haematology, .;
(2018)
Diagnosis and therapy of genetic haemochromatosis (review and 2017 update).
[Editorial comment].
British Journal of Haematology
, 181
(3)
pp. 293-303.
10.1111/bjh.15164.
|
|
Forlano, Roberta;
Stanic, Tijana;
Jayawardana, Sahan;
Mullish, Benjamin Harvey;
Yee, Michael;
Mossialos, Elias;
Goldin, Robert;
... Manousou, Pinelopi; + view all
(2024)
A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies.
Liver International
, 44
(1)
pp. 61-71.
10.1111/liv.15730.
|
|
Ginès, P;
Castera, L;
Lammert, F;
Graupera, I;
Serra-Burriel, M;
Allen, AM;
Wong, VW-S;
... LiverScreen Consortium Investigators; + view all
(2022)
Population screening for liver fibrosis: towards early diagnosis and intervention for chronic liver diseases.
Hepatology
, 75
(1)
pp. 219-228.
10.1002/hep.32163.
|
|
Ginès, P;
Guha, IN;
Fabrellas, N;
Allen, AM;
Angeli, P;
Serra-Burriel, M;
Arslanow, A;
... Tsochatzis, EA; + view all
(2025)
Liver Health: An Emerging Concept.
Gastroenterology
, 169
(1)
4-8.e1.
10.1053/j.gastro.2024.12.039.
|
|
Gómez-Orellana, Antonio Manuel;
Rodríguez-Perálvarez, Manuel Luis;
Guijo-Rubio, David;
Gutiérrez, Pedro Antonio;
Majumdar, Avik;
McCaughan, Geoffrey W;
Taylor, Rhiannon;
... Hervás-Martínez, César; + view all
(2025)
Gender-Equity Model for Liver Allocation using Artificial Intelligence (GEMA-AI) for waiting list liver transplant prioritization.
Clinical Gastroenterology and Hepatology
10.1016/j.cgh.2024.12.010.
(In press).
|
|
|
Goyale, A;
Jain, A;
Smith, C;
Papatheodoridi, M;
Misas, MG;
Roccarina, D;
Prat, LI;
... Tsochatzis, E; + view all
(2021)
Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
PLoS One
, 16
(11)
, Article e0260313. 10.1371/journal.pone.0260313.
|
|
|
Graupera, Isabel;
Thiele, Maja;
Ma, Ann T;
Serra-Burriel, Miquel;
Pich, Judit;
Fabrellas, Núria;
Caballeria, Llorenç;
... LiverScreen Consortium investigators; + view all
(2022)
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
BMC Public Health
, 22
, Article 1385. 10.1186/s12889-022-13724-6.
|
|
|
Grgurević, Ivica;
Madir, Anita;
Trkulja, Vladimir;
Bozin, Tonci;
Aralica, Gorana;
Podrug, Kristian;
Mikolašević, Ivana;
... Pinzani, Massimo; + view all
(2022)
Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
European Journal of Clinical Investigation
, 52
(6)
, Article e13750. 10.1111/eci.13750.
|
|
Grgurevic, I;
Podrug, K;
Mikolasevic, I;
Kukla, M;
Madir, A;
Tsochatzis, EA;
(2020)
Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach.
Canadian Journal of Gastroenterology and Hepatology
, 2020
, Article 9181368. 10.1155/2020/9181368.
|
|
|
Guaraldi, G;
Maurice, JB;
Marzolini, C;
Monteith, K;
Milic, J;
Tsochatzis, E;
Bhagani, S;
... SHIVER Network; + view all
(2020)
New drugs for non-alcoholic steatohepatitis and HIV infection: great expectations with a great absent?
Hepatology
, 71
(5)
pp. 1831-1844.
10.1002/hep.31177.
|
|
Gurusamy, KS;
Tsochatzis, E;
(2018)
Primary prevention of bleeding in people with oesophageal varices due to liver cirrhosis: A network meta-analysis.
Cochrane Database of Systematic Reviews
, 2018
(9)
10.1002/14651858.CD013121.
|
|
Gurusamy, KS;
Tsochatzis, E;
(2018)
Secondary prevention of bleeding in people with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: A network meta-analysis.
Cochrane Database of Systematic Reviews
, 2018
(9)
10.1002/14651858.CD013122.
|
|
Gurusamy, KS;
Tsochatzis, E;
(2018)
Treatment for ascites in people with decompensated liver cirrhosis: A network meta-analysis.
Cochrane Database of Systematic Reviews
, 2018
(9)
10.1002/14651858.CD013123.
|
|
Gurusamy, KS;
Tsochatzis, E;
Madden, AM;
(2018)
Nutritional supplementation for non-alcohol-related fatty liver disease: A network meta-analysis.
Cochrane Database of Systematic Reviews
(10)
, Article CD013157. 10.1002/14651858.CD013157.
|
|
Gurusamy, KS;
Tsochatzis, E;
Madden, AM;
(2018)
Lifestyle modifications for non-alcohol related fatty liver disease: A network meta-analysis.
Cochrane Database of Systematic Reviews
, 2018
(10)
, Article CD013156. 10.1002/14651858.CD013156.
|
|
Gurusamy, KS;
Walmsley, M;
Davidson, BR;
Frier, C;
Fuller, B;
Madden, A;
Masson, S;
... Yeoman, A; + view all
(2019)
Top research priorities in liver and gallbladder disorders in the UK.
BMJ Open
, 9
(3)
, Article e025045. 10.1136/bmjopen-2018-025045.
|
|
Gurusamy, KS;
Wilson, P;
Tsochatzis, E;
(2018)
Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: A network meta-analysis.
Cochrane Database of Systematic Reviews
, 2018
(9)
10.1002/14651858.CD013125.
|
|
Gurusamy, KS;
Wilson, P;
Tsochatzis, E;
(2018)
Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: A network meta-analysis.
Cochrane Database of Systematic Reviews
, 2018
(9)
10.1002/14651858.CD013120.
|
|
Hall, A;
Covelli, C;
Manuguerra, R;
Luong, TV;
Buzzetti, E;
Tsochatzis, E;
Pinzani, M;
(2017)
Transaminase abnormalities and adaptations of the liver lobule manifest at specific cut-offs of steatosis.
Sci Rep
, 7
, Article 40977. 10.1038/srep40977.
|
|
|
Hansen, Emil Deleuran;
Torp, Nikolaj;
Johansen, Stine;
Hansen, Johanne Kragh;
Bergmann, Marianne Lerbaek;
Hansen, Camilla Dalby;
Detlefsen, Sonke;
... Israelsen, Mads; + view all
(2025)
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake.
JHEP Reports
, 7
(1)
, Article 101200. 10.1016/j.jhepr.2024.101200.
|
|
|
Huttman, Marc;
Parigi, Tommaso Lorenzo;
Zoncapè, Mirko;
Liguori, Antonio;
Kalafateli, Maria;
Noel-Storr, Anna H;
Casazza, Giovanni;
(2024)
Liver fibrosis stage based on the four factors (FIB-4) score or Forns index in adults with chronic hepatitis C.
Cochrane Database of Systematic Reviews
, 8
(8)
, Article CD011929. 10.1002/14651858.CD011929.pub2.
|
|
Iogna Prat, L;
Roccarina, D;
Lever, R;
Lombardi, R;
Rodger, A;
Hall, A;
Luong, TV;
... Tsochatzis, EA; + view all
(2019)
Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies.
Journal of Acquired Immune Deficiency Syndromes
, 80
(4)
pp. 474-480.
10.1097/QAI.0000000000001942.
|
|
Iogna Prat, L;
Tsochatzis, EA;
(2018)
The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD).
Hormones
, 17
(2)
pp. 219-229.
10.1007/s42000-018-0021-9.
|
|
Iogna Prat, L;
Wilson, P;
Freeman, SC;
Sutton, AJ;
Cooper, NJ;
Roccarina, D;
Benmassaoud, A;
... Gurusamy, KS; + view all
(2019)
Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 2019
(9)
, Article CD013120. 10.1002/14651858.CD013120.pub2.
|
|
Israelsen, M;
Francque, S;
Tsochatzis, EA;
Krag, A;
(2024)
Steatotic liver disease.
The Lancet
, 404
(10464)
pp. 1761-1778.
10.1016/S0140-6736(24)01811-7.
|
|
Israelsen, M;
Guerrero Misas, M;
Tsochatzis, EA;
(2021)
Editorial: can quantitative fibrosis assessment be used to enhance prediction of outcomes in patients with alcohol-related liver disease? Authors' reply.
[Editorial comment].
Alimentary Pharmacology & Therapeutics
, 53
(1)
pp. 185-186.
10.1111/apt.16150.
|
|
Israelsen, M;
Misas, MG;
Koutsoumourakis, A;
Hall, A;
Covelli, C;
Buzzetti, E;
Prat, LI;
... Tsochatzis, EA; + view all
(2021)
Collagen proportionate area predicts long-term mortality in patients with alcoholic hepatitis.
Digestive and Liver Disease
10.1016/j.dld.2021.08.021.
(In press).
|
|
|
Israelsen, Mads;
Torp, Nikolaj;
Johansen, Stine;
Hansen, Camilla Dalby;
Hansen, Emil Deleuran;
Thorhauge, Katrine;
Hansen, Johanne Kragh;
... GALAXY Consortium; + view all
(2024)
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
The Lancet Gastroenterology & Hepatology
, 9
(3)
pp. 218-228.
10.1016/S2468-1253(23)00443-0.
|
|
Israelsen, M;
Guerrero Misas, M;
Koutsoumourakis, A;
Huang, Y;
Thiele, M;
Hall, A;
Rasmussen, D;
... Tsochatzis, EA; + view all
(2020)
Collagen proportionate area predicts clinical outcomes in
patients with alcohol-related liver disease.
Alimentary Pharmacology and Therapeutics
10.1111/apt.16111.
(In press).
|
|
|
Jeffrey, Angus W;
Chen, James;
Chin, Andrew;
Tsochatzis, Emmanuel A;
Majumdar, Avik;
Calzadilla-Bertot, Luis;
Wallace, Michael C;
... Adams, Leon A; + view all
(2025)
Noninvasive Prediction Models of First Decompensation in Compensated Advanced Chronic Liver Disease: A Meta-Analysis.
Clinical Gastroenterology and Hepatology
10.1016/j.cgh.2025.10.002.
|
|
Johansen, Stine;
Åberg, Fredrik;
Tsochatzis, Emmanuel A;
Krag, Aleksander;
(2025)
Screening for advanced steatotic liver disease.
The Lancet Gastroenterology & Hepatology
10.1016/S2468-1253(25)00097-4.
(In press).
|
|
Kablawi, Dana;
Milic, Jovana;
Thomas, Tyler;
Tadjo, Thierry Fotsing;
Cinque, Felice;
Elgretli, Wesal;
Gioe, Claudia;
... Sebastiani, Giada; + view all
(2024)
Metabolic dysfunction-associated steatohepatitis exhibits sex differences in people with HIV.
HIV Medicine
, 25
(11)
pp. 1259-1269.
10.1111/hiv.13697.
|
|
|
Kalafateli, M;
Buzzetti, E;
Thorburn, D;
Davidson, BR;
Tsochatzis, E;
Gurusamy, KS;
(2018)
Pharmacological interventions for acute hepatitis C infection.
Cochrane Database of Systematic Reviews
, 12
, Article CD011644. 10.1002/14651858.CD011644.pub3.
|
|
Kalafateli, M;
Buzzetti, E;
Thorburn, D;
Davidson, BR;
Tsochatzis, E;
Gurusamy, KS;
(2017)
Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
Cochrane Database of Systematic Reviews
(3)
, Article CD011644. 10.1002/14651858.CD011644.pub2.
|
|
Kalafateli, M;
Mantzoukis, K;
Choi Yau, Y;
Mohammad, AO;
Arora, S;
Rodrigues, S;
de Vos, M;
... Tsochatzis, EA; + view all
(2017)
Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score.
Journal of Cachexia, Sarcopenia and Muscle
, 8
(1)
pp. 113-121.
10.1002/jcsm.12095.
|
|
|
Kalafateli, M;
Tsochatzis, EA;
(2017)
Reply to "The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort.".
Hepatology
, 66
(4)
pp. 1361-1362.
10.1002/hep.29391.
|
|
Kalafateli, M;
Wickham, F;
Burniston, M;
Cholongitas, E;
Theocharidou, E;
Garcovich, M;
O'Beirne, J;
... Tsochatzis, E; + view all
(2017)
Development and Validation of a Mathematical Equation to Estimate Glomerular Filtration Rate in Cirrhosis: The Royal Free Hospital Cirrhosis Glomerular Filtration Rate (vol 65, pg 582, 2017).
[Corrigendum].
Hepatology
, 66
(3)
p. 1010.
10.1002/hep.29294.
|
|
Kalafateli, M;
Wickham, F;
Burniston, M;
Cholongitas, E;
Theocharidou, E;
Garcovich, M;
O'Beirne, J;
... Tsochatzis, EA; + view all
(2017)
Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
Hepatology
, 65
(2)
pp. 582-591.
10.1002/hep.28891.
|
|
Kalafateli, M;
Zisimopoulos, K;
Vourli, G;
Rigamonti, C;
Goulis, J;
Manesis, E;
Manolakopoulos, S;
... Triantos, C; + view all
(2017)
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.
Digestive Diseases and Sciences
, 62
(5)
pp. 1363-1372.
10.1007/s10620-017-4504-3.
|
|
Kalligeros, Markos;
Tsochatzis, Emmanuel A;
(2024)
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease.
Hepatobiliary Surgery and Nutrition
, 13
(2)
pp. 311-313.
10.21037/hbsn-23-654.
|
|
King, Ji Jade;
Halliday, Neil;
Mantovani, Anna;
Gerussi, Alessio;
Wey, Emmanuel Q;
Tan, Jaclyn;
Ryan, Jennifer;
... Westbrook, Rachel H; + view all
(2023)
Bacterascites confers poor patient prognosis beyond MELD prediction.
Liver Transplantation
, 29
(4)
pp. 356-364.
10.1097/LVT.0000000000000068.
|
|
Komolafe, O;
Buzzetti, E;
Linden, A;
Best, LM;
Madden, AM;
Roberts, D;
Chase, TJ;
... Gurusamy, KS; + view all
(2021)
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 2021
(7)
, Article CD013157. 10.1002/14651858.CD013157.pub2.
|
|
Komolafe, O;
Roberts, D;
Freeman, SC;
Wilson, P;
Sutton, AJ;
Cooper, NJ;
Pavlov, CS;
... Gurusamy, KS; + view all
(2020)
Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 1
, Article CD013125. 10.1002/14651858.CD013125.pub2.
|
|
Kong, Yuanyuan;
Lv, Tingting;
Li, Min;
Zhao, Lianghui;
Meng, Tongtong;
Wu, Shanshan;
Wei, Wei;
... Jia, Jidong; + view all
(2022)
Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease.
Hepatology International
, 16
pp. 1052-1063.
10.1007/s12072-022-10369-w.
|
|
Koukias, N;
Buzzetti, E;
Tsochatzis, E;
(2017)
Intestinal hormones, gut microbiota and nonalcoholic fatty liver disease.
Minerva Endocrinologica
, 42
(2)
pp. 184-194.
10.23736/S0391-1977.16.02567-0.
|
|
Lai, Jimmy Che-To;
Yang, Boyu;
Lee, Hye Won;
Lin, Huapeng;
Tsochatzis, Emmanuel A;
Petta, Salvatore;
Bugianesi, Elisabetta;
... Yip, Terry Cheuk-Fung; + view all
(2025)
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.
Gut
10.1136/gutjnl-2025-334981.
(In press).
|
|
Lai, Quirino;
De Stefano, Carmine;
Emond, Jean;
Bhangui, Prashant;
Ikegami, Toru;
Schaefer, Benedikt;
Hoppe-Lotichius, Maria;
... EurHeCaLT and the West-East LT Study Group; + view all
(2023)
Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence.
Cancer Communications
10.1002/cac2.12468.
(In press).
|
|
|
Lai, Quirino;
Viveiros, Andre;
Iesari, Samuele;
Vitale, Alessandro;
Mennini, Gianluca;
Onali, Simona;
Hoppe-Lotichius, Maria;
... Lerut, Jan P; + view all
(2022)
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation.
Frontiers in Oncology
, 12
, Article 877107. 10.3389/fonc.2022.877107.
|
|
Lai, Q;
Vitale, A;
Iesari, S;
Finkenstedt, A;
Mennini, G;
Onali, S;
Hoppe-Lotichius, M;
... European Hepatocellular Cancer Liver Transplant Study Group, .; + view all
(2019)
The intention‐to‐treat effect of bridging treatments in the setting of Milan Criteria‐IN patients waiting for liver transplantation.
Liver Transplantation
, 25
(7)
pp. 1022-1033.
10.1002/lt.25492.
|
|
Lai, Q;
Vitale, A;
Iesari, S;
Finkenstedt, A;
Mennini, G;
Spoletini, G;
Hoppe-Lotichius, M;
... European Hepatocellular Cancer Liver Transplant Study Group; + view all
(2017)
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
Hepatology
, 66
(6)
pp. 1910-1919.
10.1002/hep.29342.
|
|
Lazaridis, N;
Tsochatzis, E;
(2017)
Current and future treatment options in non-alcoholic steatohepatitis (NASH).
Expert Review of Gastroenterology & Hepatology
, 11
(4)
pp. 357-369.
10.1080/17474124.2017.1293523.
|
|
Lazarus, J;
Anstee, QM;
Hagstrom, H;
Cusi, K;
Cortez-Pinto, H;
Mark, HE;
Roden, M;
... Schattenberg, JM; + view all
(2021)
Defining comprehensive models of care for NAFLD.
Nature Reviews Gastroenterology and Hepatology
, 18
pp. 717-729.
10.1038/s41575-021-00477-7.
|
|
Lazarus, J;
Mark, HE;
Anstee, QM;
Arab, JP;
Batterham, RL;
Castera, L;
Cortez-Pinto, H;
... Zelber-Sagi, S; + view all
(2022)
Advancing the global public health agenda for NAFLD: a consensus statement.
Nature Reviews Gastroenterology & Hepatology
, 19
pp. 60-78.
10.1038/s41575-021-00523-4.
|
|
Lazarus, J;
Mark, HE;
Colombo, M;
Demaio, S;
Dillon, JF;
George, J;
Hagstroem, H;
... Huang, TT-K; + view all
(2021)
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach.
Alimentary Pharmacology & Therapeutics
, 55
(2)
pp. 234-243.
10.1111/apt.16720.
|
|
|
Lazarus, Jeffrey V;
Ivancovsky Wajcman, Dana;
Pannain, Silvana;
Brennan, Paul N;
Manolas, Melina I;
Jepsen, Peter;
Treloar, Carla;
... Villota-Rivas, Marcela; + view all
(2025)
The People-First Liver Charter.
Nature Medicine
10.1038/s41591-025-03759-8.
(In press).
|
|
Lazarus, Jeffrey V;
Mark, Henry E;
Allen, Alina M;
Arab, Juan Pablo;
Carrieri, Patrizia;
Noureddin, Mazen;
Alazawi, William;
... Healthy Livers, Healthy Lives, Collaborators; + view all
(2023)
A global action agenda for turning the tide on fatty liver disease.
Hepatology
10.1097/HEP.0000000000000545.
(In press).
|
|
|
Lazarus, Jeffrey V;
Mark, Henry E;
Allen, Alina M;
Arab, Juan Pablo;
Carrieri, Patrizia;
Noureddin, Mazen;
Alazawi, William;
... Healthy Livers, Healthy Lives, Collaborators; + view all
(2023)
A global research priority agenda to advance public health responses to fatty liver disease.
Journal of Hepatology
10.1016/j.jhep.2023.04.035.
(In press).
|
|
Lazarus, JV;
Castera, L;
Mark, HE;
Allen, AM;
Adams, LA;
Anstee, QM;
Arrese, M;
... Tsochatzis, EA; + view all
(2022)
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice.
JHEP Reports
, Article 100596. 10.1016/j.jhepr.2022.100596.
(In press).
|
|
Lazarus, JV;
Mark, HE;
Villota-Rivas, M;
Palayew, A;
Carrieri, P;
Colombo, M;
Ekstedt, M;
... NAFLD policy review collaborators; + view all
(2021)
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Journal of Hepatology
10.1016/j.jhep.2021.10.025.
(In press).
|
|
|
Li, Y;
Li, H;
Zhu, Q;
Tsochatzis, E;
Wang, R;
Guo, X;
Qi, X;
(2019)
Effect of acute upper gastrointestinal bleeding manifestations at admission on the in-hospital outcomes of liver cirrhosis: hematemesis versus melena without hematemesis.
European Journal of Gastroenterology & Hepatology
, 31
(11)
pp. 1334-1341.
10.1097/MEG.0000000000001524.
|
|
Liguori, Antonio;
Zoncape, Mirko;
Casazza, Giovanni;
Easterbrook, Philippa;
Tsochatzis, Emmanuel A;
(2025)
Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis.
The Lancet Gastroenterology & Hepatology
, 10
(4)
pp. 332-349.
10.1016/S2468-1253(24)00437-0.
|
|
|
Liguori, Antonio;
Zoncapè, Mirko;
Tsochatzis, Emmanuel A;
(2022)
Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease.
Revista Española De Enfermedades Digestivas
, 114
(4)
pp. 191-194.
10.17235/reed.2022.8718/2022.
|
|
Lin, Huapeng;
Lee, Hye Won;
Yip, Terry Cheuk-Fung;
Tsochatzis, Emmanuel;
Petta, Salvatore;
Bugianesi, Elisabetta;
Yoneda, Masato;
... Wong, Vincent Wai-Sun; + view all
(2024)
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
JAMA: Journal of the American Medical Association
10.1001/jama.2024.1447.
(In press).
|
|
Liu, B;
Zhang, Y;
Chen, H;
Li, W;
Tsochatzis, E;
(2022)
The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma.
Cochrane Database of Systematic Reviews
, 1
, Article CD013345. 10.1002/14651858.CD013345.pub2.
|
|
|
Liu, Wen-Yue;
Huang, Shanshan;
Ji, Hongsheng;
Kim, Seung Up;
Yip, Terry Cheuk-Fung;
Wong, Grace Lai-Hung;
Petta, Salvatore;
... VCTE-Prognosis Study Group; + view all
(2025)
From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic Perspective.
Gastroenterology
10.1053/j.gastro.2025.02.034.
(In press).
|
|
Lo Re, O;
Mazza, T;
Giallongo, S;
Sanna, P;
Rappa, F;
Tu, VL;
Li Volti, G;
... Vinciguerra, M; + view all
(2020)
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4⁺ CD25⁺ FoxP3⁺ regulatory T cells activation.
Theranostics
, 10
(2)
pp. 910-924.
10.7150/thno.35045.
|
|
|
Lombardi, R;
Lever, R;
Smith, C;
Marshall, N;
Rodger, A;
Bhagani, S;
Tsochatzis, E;
(2017)
Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers.
Annals of Gastroenterology
, 30
(3)
pp. 349-356.
10.20524/aog.2017.0141.
|
|
Lombardi, R;
Onali, S;
Thorburn, D;
Davidson, BR;
Gurusamy, KS;
Tsochatzis, E;
(2017)
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
Cochrane Database of Systematic Reviews
, 3
, Article CD011640. 10.1002/14651858.CD011640.pub2.
|
|
Lombardi, R;
Sambatakou, H;
Mariolis, I;
Cokkinos, D;
Papatheodoridis, GV;
Tsochatzis, EA;
(2016)
Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection.
Digestive and Liver Disease
, 48
(12)
pp. 1471-1477.
10.1016/j.dld.2016.08.117.
|
|
Luong, TV;
Abou-Beih, S;
Watkins, J;
Tsochatzis, E;
Pinzani, M;
Davison, S;
Hall, A;
(2020)
Elastic fibres in alcoholic liver disease.
Scientific Reports
, 10
, Article 20098. 10.1038/s41598-020-77007-z.
|
|
|
Madir, Anita;
Grgurevic, Ivica;
Tsochatzis, Emmanuel A;
Pinzani, Massimo;
(2024)
Portal hypertension in patients with nonalcoholic fatty liver disease:
Current knowledge and challenges.
World Journal of Gastroenterology
, 30
(4)
pp. 290-307.
10.3748/wjg.v30.i4.290.
|
|
|
Maimone, S;
Saffioti, F;
Filomia, R;
Alibrandi, A;
Isgrò, G;
Calvaruso, V;
Xirouchakis, E;
... Patch, D; + view all
(2019)
Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).
Digestive Diseases and Sciences
, 64
pp. 1335-1345.
10.1007/s10620-018-5412-x.
|
|
Majumdar, A;
Tsochatzis, EA;
(2022)
Binge drinking and fibrogenesis: More than just a hangover.
Liver International
, 42
(1)
pp. 6-8.
10.1111/liv.15119.
|
|
Majumdar, A;
Tsochatzis, EA;
(2021)
Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
[Letter].
Gut
10.1136/gutjnl-2021-325994.
(In press).
|
|
|
Majumdar, A;
Verbeek, J;
Tsochatzis, EA;
(2021)
Non-alcoholic fatty liver disease: Current therapeutic options.
Current Opinion in Pharmacology
, 61
pp. 98-105.
10.1016/j.coph.2021.09.007.
|
|
Majumdar, Avik;
Rodríguez-Perálvarez, Manuel Luis;
Tsochatzis, Emmanuel;
(2025)
GEMA-Na: A crucial step in solving the MELD-creatinine dilemma.
Journal of Hepatology
, 83
(1)
e49-e50.
10.1016/j.jhep.2024.11.016.
|
|
Majumdar, A;
Campos, S;
Gurusamy, K;
Pinzani, M;
Tsochatzis, EA;
(2020)
Defining the minimum acceptable diagnostic accuracy of non-invasive fibrosis testing in cirrhosis: a decision analytic modelling study.
Hepatology
, 71
(2)
pp. 627-642.
10.1002/hep.30846.
|
|
Majumdar, A;
Roccarina, D;
Thorburn, D;
Davidson, BR;
Tsochatzis, E;
Gurusamy, KS;
(2017)
Management of people with early- or very early-stage hepatocellular carcinoma.
Cochrane Database of Systematic Reviews
, 2017
(3)
, Article CD011650. 10.1002/14651858.CD011650.pub2.
|
|
Majumdar, A;
Tsochatzis, E;
(2016)
Biomarkers of bacterial translocation in advanced chronic liver disease: the key to individualizing prognosis.
Ann Gastroenterol
, 29
(1)
pp. 1-2.
|
|
|
Majumdar, A;
Tsochatzis, EA;
(2020)
Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
Metabolism
, 111
(S)
, Article 154291. 10.1016/j.metabol.2020.154291.
|
|
Majumdar, A;
Tsochatzis, EA;
(2020)
Curve Your Enthusiasm: The Decision to Use Expanded or Original Baveno VI Criteria to Exclude High-Risk Varices.
Clinical Gastroenterology and Hepatology
, 18
(5)
pp. 1243-1244.
10.1016/j.cgh.2019.09.028.
|
|
Mallet, V;
Parlati, L;
Martinino, A;
Scarano Pereira, JP;
Navas Jimenez, C;
Sakka, M;
Bouam, S;
... Demosthenes research group, .; + view all
(2022)
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus.
Journal of Hepatology
, 76
(2)
pp. 265-274.
10.1016/j.jhep.2021.09.030.
|
|
Mallet, V;
Parlati, L;
Vallet-Pichard, A;
Terris, B;
Tsochatzis, E;
Sogni, P;
Pol, S;
(2019)
L’index FIB-4 pour faire le diagnostic de fibrose hépatique avancée au cours de la stéatose hépatique = FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients.
La Presse Médicale
, 48
(12)
pp. 1484-1488.
10.1016/j.lpm.2019.10.017.
|
|
Manousou, P;
Cholongitas, E;
Samonakis, D;
Tsochatzis, E;
Corbani, A;
Dhillon, AP;
Davidson, J;
... Burroughs, AK; + view all
(2013)
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.
Gut
, 63
1005- 1013.
10.1136/gutjnl-2013-305606.
|
|
|
Manousou, P;
Cholongitas, E;
Samonakis, D;
Tsochatzis, E;
Corbani, A;
Rodríguez-Perálvarez, M;
Patch, D;
... McCormick, PA; + view all
(2014)
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: Randomised trial long term outcomes.
Gut
, 63
(6)
1005 - 1013.
10.1136/gutjnl-2013-305606.
|
|
|
Mantzoukis, K;
Rodríguez-Perálvarez, M;
Buzzetti, E;
Thorburn, D;
Davidson, BR;
Tsochatzis, E;
Gurusamy, KS;
(2017)
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
Cochrane Database of Systematic Reviews
, 3
, Article CD011645. 10.1002/14651858.CD011645.pub2.
|
|
Maurice, JB;
Goldin, R;
Hall, A;
Price, JC;
Sebastiani, G;
Morse, CG;
Prat, L;
... Lemoine, M; + view all
(2021)
Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection.
Clinical Infectious Diseases
, 73
(7)
e2184-e2193.
10.1093/cid/ciaa1302.
|
|
Maurice, J;
Brodkin, E;
Arnold, F;
Navaratnam, A;
Paine, H;
Khawar, S;
Dhar, A;
... Westbrook, RH; + view all
(2016)
Validation of the Baveno Vi Criteria to Identify Low Risk Cirrhotic Patients not Requiring Endoscopic Surveillance for Varices.
Journal of Hepatology
, 65
(5)
pp. 899-905.
10.1016/j.jhep.2016.06.021.
|
|
Maurice, J;
Pinzani, M;
Tsochatzis, E;
Westbrook, RH;
(2017)
Reply to letter by Angelo Zamban De Mattos.
Journal of Hepatology
10.1016/j.jhep.2017.02.030.
(In press).
|
|
Maurice, JB;
Garvey, L;
Tsochatzis, EA;
Wiltshire, M;
Cooke, G;
Guppy, N;
McDonald, J;
... Lemoine, M; + view all
(2019)
Monocyte-Macrophage activation is associated with NAFLD and liver fibrosis in HIV mono-infection independently of the gut microbiome and bacterial translocation.
AIDS
, 33
(5)
pp. 805-814.
10.1097/QAD.0000000000002133.
|
|
McPherson, Stuart;
Armstrong, Matthew J;
Cobbold, Jeremy F;
Corless, Lynsey;
Anstee, Quentin M;
Aspinall, Richard J;
Barclay, Stephen T;
... Alazawi, William; + view all
(2022)
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group.
The Lancet Gastroenterology & Hepatology
, 7
(8)
pp. 755-769.
10.1016/S2468-1253(22)00061-9.
|
|
Metwally, Mayada;
Berg, Thomas;
Tsochatzis, Emmanuel A;
Eslam, Mohammed;
(2022)
Translation Reprogramming as a Novel Therapeutic Target in MAFLD.
Advanced Biology
, 6
(5)
, Article 2101298. 10.1002/adbi.202101298.
|
|
Moctezuma-Velazquez, C;
Saffioti, F;
Tasayco-Huaman, S;
Casu, S;
Mason, A;
Roccarina, D;
Vargas, V;
... Abraldes, JG; + view all
(2018)
Non-invasive Prediction of High-risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
The American Journal of Gastroenterology
, 114
(3)
pp. 446-452.
10.1038/s41395-018-0265-7.
|
|
Morgan, A;
Hartmanis, S;
Tsochatzis, E;
Newsome, PN;
Ryder, SD;
Elliott, R;
Floros, L;
... Pezzullo, L; + view all
(2021)
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018.
The European Journal of Health Economics
10.1007/s10198-020-01256-y.
(In press).
|
|
|
Mózes, Ferenc E;
Lee, Jenny A;
Vali, Yasaman;
Alzoubi, Osama;
Staufer, Katharina;
Trauner, Michael;
Paternostro, Rafael;
... LITMUS, investigators; + view all
(2023)
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
The Lancet Gastroenterology & Hepatology
, 8
(8)
pp. 704-713.
10.1016/S2468-1253(23)00141-3.
|
|
Mózes, Ferenc E;
Lee, Jenny A;
Vali, Yasaman;
Selvaraj, Emmanuel A;
Jayaswal, Arjun NA;
Boursier, Jérôme;
de Lédinghen, Victor;
... Pavlides, Michael; + view all
(2024)
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.
Liver International
10.1111/liv.15914.
(In press).
|
|
Newsome, PN;
Sasso, M;
Deeks, JJ;
Paredes, A;
Boursier, J;
Chan, W-K;
Yilmaz, Y;
... Harrison, SA; + view all
(2020)
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
The Lancet Gastroenterology and Hepatology
, 5
pp. 362-373.
10.1016/S2468-1253(19)30383-8.
|
|
Noureddin, Mazen;
Wei, Lai;
Castera, Laurent;
Tsochatzis, Emmanuel A;
(2024)
Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic-Dysfunction Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella.
Clinical Gastroenterology and Hepatology
, 22
(1)
pp. 9-11.
10.1016/j.cgh.2023.09.034.
|
|
Oduwole, O;
Ding, C;
Bitar, N;
Nair, D;
Salter, S;
Silverman, M;
Allen, R;
... Britton, A; + view all
(2025)
Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults.
npj Gut and Liver
, 2
, Article 10. 10.1038/s44355-025-00024-0.
|
|
|
Onali, S;
Kalafateli, M;
Majumdar, A;
Westbrook, R;
O'Beirne, J;
Leandro, G;
Patch, D;
(2017)
Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites.
Liver International
, 37
(9)
pp. 1334-1344.
10.1111/liv.13409.
|
|
Pallini, G;
Tsochatzis, EA;
(2021)
NAFLD: Diagnostic Algorithms for Regulating Patient Fluxes.
Current Pharmaceutical Design
, 27
(27)
10.2174/1381612827666210127120748.
|
|
Papastergiou, V;
Tsochatzis, EA;
Pieri, G;
Thalassinos, E;
Dhar, A;
Bruno, S;
Karatapanis, S;
... Burroughs, AK; + view all
(2014)
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.
Alimentary Pharmacology & Therapeutics
, 39
(7)
10.1111/apt.12654.
|
|
|
Papastergiou, V;
Tsochatzis, EA;
Pieri, G;
Thalassinos, E;
Dhar, A;
Karatapanis, S;
O'Beirne, J;
... Luong, TV; + view all
(2014)
Nine scoring models for short-term mortality in alcoholic hepatitis: Cross-validation in a biopsy-proven cohort.
Alimentary Pharmacology and Therapeutics
, 39
(7)
721 - 732.
10.1111/apt.12654.
|
|
|
Papastergiou, V;
Tsochatzis, EA;
Rodriquez-Peralvarez, M;
Thalassinos, E;
Pieri, G;
Manousou, P;
Germani, G;
... Burroughs, AK; + view all
(2013)
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
, 38
(11-12)
1354 - 1364.
10.1111/apt.12522.
|
|
|
Papatheodoridi, M;
Hall, AR;
Rodríguez-Perálvarez, M;
Pieri, G;
Germani, G;
Gale, JD;
Burgess, GC;
... Tsochatzis, E; + view all
(2021)
Histological sub‐classification of cirrhosis using collagen proportionate area in patients with chronic hepatitis C.
Liver International
, 41
(7)
pp. 1608-1613.
10.1111/liv.14909.
|
|
Papatheodoridi, M;
Hiriart, JB;
Lupsor-Platon, M;
Bronte, F;
Boursier, J;
Elshaarawy, O;
Marra, F;
... Tsochatzis, EA; + view all
(2021)
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
Journal of Hepatology
, 74
(5)
pp. 1109-1116.
10.1016/j.jhep.2020.11.050.
|
|
Papatheodoridi, M;
Pallini, G;
Aithal, G;
Lim, HK;
Cobbold, J;
Plaz Torres, MC;
Misas, MG;
... Tsochatzis, EA; + view all
(2023)
Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK Study.
Clinical Gastroenterology and Hepatology
10.1016/j.cgh.2023.04.018.
(In press).
|
|
Papatheodoridi, M;
Pinzani, M;
Tsochatzis, E;
(2021)
Reply to: “Baveno VI elastography criteria for ruling in cACLD works well in patients with MAFLD” and “Transient elastography in chronic liver disease: Beware of the cut-offs!”.
[Letter].
Journal of Hepatology
, 75
(5)
p. 1247.
10.1016/j.jhep.2021.07.036.
|
|
Papatheodoridi, M;
Pinzani, M;
Tsochatzis, E;
(2021)
Reply to: "Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)?".
Journal of Hepatology
, 75
(3)
pp. 752-753.
10.1016/j.jhep.2021.06.007.
|
|
Papatheodoridi, Margarita;
De Ledinghen, Victor;
Lupsor-Platon, Monica;
Bronte, Fabrizio;
Boursier, Jerome;
Elshaarawy, Omar;
Marra, Fabio;
... Tsochatzis, Emmanuel A; + view all
(2024)
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms.
Journal of Hepatology
, 81
(4)
pp. 590-599.
10.1016/j.jhep.2024.05.021.
|
|
Parikh, P;
Ryan, JD;
Tsochatzis, EA;
(2017)
Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.
Annals of Translational Medicine
, 5
(3)
, Article 40. 10.21037/atm.2017.01.28.
|
|
Parisi, I;
O'Beirne, J;
Rossi, RE;
Tsochatzis, E;
Manousou, P;
Theocharidou, E;
Hamilton, M;
... Burroughs, AK; + view all
(2016)
Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab.
European Journal of Gastroenterology & Hepatology
, 28
(7)
pp. 786-791.
10.1097/MEG.0000000000000624.
|
|
Parisi, I;
Tsochatzis, E;
Wijewantha, H;
Rodríguez-Perálvarez, M;
De Luca, L;
Manousou, P;
Fatourou, E;
... Burroughs, AK; + view all
(2014)
Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma (HCC) in patients within Milan criteria.
Liver Transplantation
, 20
(11)
pp. 1327-1335.
10.1002/lt.23969.
|
|
|
Pavlov, CS;
Casazza, G;
Nikolova, D;
Tsochatzis, E;
Ivashkin, VT;
Gluud, C;
(2016)
FibroTest, transient elastography method, and combined FibroTest and transient elastography method for diagnosis of severe hepatic fibrosis and cirrhosis in adults with chronic hepatitis C.
Cochrane Database of Systematic Reviews
, 2016
(7)
, Article CD012291. 10.1002/14651858.CD012291.
|
|
Pavlov, CS;
Casazza, G;
Semenistaia, M;
Nikolova, D;
Tsochatzis, E;
Liusina, E;
Ivashkin, VT;
(2016)
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.
Cochrane Database of Systematic Reviews
, 3
CD011602.
10.1002/14651858.CD011602.pub2.
|
|
Pavlov, CS;
Tsochatzis, E;
Casazza, G;
Nikolova, D;
Volcek, E;
Gluud, C;
(2016)
Glucocorticosteroids for people with alcoholic hepatitis.
Cochrane Database of Systematic Reviews
, 6
, Article CD001511. 10.1002/14651858.CD001511.pub2.
|
|
Pavlov, CS;
Varganova, DL;
Casazza, G;
Tsochatzis, E;
Nikolova, D;
Gluud, C;
(2019)
Glucocorticosteroids for people with alcoholic hepatitis.
Cochrane Database of Systematic Reviews
, 2019
(4)
10.1002/14651858.CD001511.pub4.
|
|
Pavlov, CS;
Varganova, DL;
Casazza, G;
Tsochatzis, E;
Nikolova, D;
Gluud, C;
(2017)
Glucocorticosteroids for people with alcoholic hepatitis.
Cochrane Database of Systematic Reviews
, 11
, Article CD001511. 10.1002/14651858.CD001511.pub3.
|
|
Pericàs, Juan M;
Anstee, Quentin M;
Augustin, Salvador;
Bataller, Ramón;
Berzigotti, Annalisa;
Ciudin, Andreea;
Francque, Sven;
... Genescà, Joan; + view all
(2024)
A roadmap for clinical trials in MASH-related compensated cirrhosis.
Nature Reviews Gastroenterology and Hepatology
, 21
pp. 809-823.
10.1038/s41575-024-00955-8.
|
|
Petroff, D;
Blank, V;
Newsome, PN;
Shalimar, MD;
Voican, CS;
Thiele, M;
de Lédinghen, V;
... Karlas, T; + view all
(2021)
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.
The Lancet Gastroenterology & Hepatology
, 6
(3)
pp. 185-198.
10.1016/S2468-1253(20)30357-5.
|
|
Pizzo, Elena;
Avsar, Tuba Saygin;
Abraldes, Juan G;
Genesca, Joan;
Tsochatzis, Emmanuel A;
(2024)
Cost-Effectiveness of the Baveno VI Criteria Compared With Endoscopy for High-Risk Varices in Patients With Child-Pugh A Cirrhosis.
Clinical Gastroenterology and Hepatology
, 22
(10)
pp. 2053-2061.
10.1016/j.cgh.2024.05.012.
|
|
Plaz Torres, MC;
Best, LM;
Freeman, SC;
Roberts, D;
Cooper, NJ;
Sutton, AJ;
Roccarina, D;
... Gurusamy, KS; + view all
(2021)
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 3
, Article CD013122. 10.1002/14651858.CD013122.pub2.
|
|
Polyzos, SA;
Kang, ES;
Tsochatzis, EA;
Kechagias, S;
Ekstedt, M;
Xanthakos, S;
Lonardo, A;
... Mantzoros, CS; + view all
(2020)
Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name.
Metabolism
, 113
, Article 154413. 10.1016/j.metabol.2020.154413.
|
|
Polyzos, SA;
Kechagias, S;
Tsochatzis, EA;
(2021)
Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations.
Alimentary Pharmacology and Therapeutics
, 54
(8)
pp. 1013-1025.
10.1111/apt.16575.
|
|
Pons, M;
Augustin, S;
Scheiner, B;
Guillaume, M;
Rosselli, M;
Rodrigues, SG;
Stefanescu, H;
... Genescà, J; + view all
(2020)
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
The American Journal of Gastroenterology
10.14309/ajg.0000000000000994.
(In press).
|
|
Pose, Elisa;
Piano, Salvatore;
Thiele, Maja;
Fabrellas, Núria;
Tsochatzis, Emmanuel A;
Ginès, Pere;
(2025)
Moving diagnosis of liver fibrosis into the community.
Journal of Hepatology
10.1016/j.jhep.2025.01.026.
(In press).
|
|
Praktiknjo, M;
Simón-Talero, M;
Römer, J;
Roccarina, D;
Martínez, J;
Lampichler, K;
Baiges, A;
... Baveno VI-SPSS group of the Baveno Cooperation, .; + view all
(2020)
Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
Journal of Hepatology
10.1016/j.jhep.2019.12.021.
(In press).
|
|
|
Prat, LI;
Tsochatzis, EA;
(2019)
Human Immunodeficiency Virus and Fatty Liver: The Perfect Storm or a Storm in a Teacup?
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
, 81
(1)
E25-E26.
10.1097/QAI.0000000000001995.
|
|
Prat, LI;
Tsochatzis, EA;
(2020)
Pediatric NAFLD: lessons from the gut.
Hepatobiliary Surgery and Nutrition
, 9
(4)
pp. 534-536.
10.21037/hbsn.2020.01.06.
|
|
Rabbat, Joseph;
Yang, Boyu;
Lee, Hye Won;
Lin, Huapeng;
Tsochatzis, Emmanuel;
Petta, Salvatore;
Bugianesi, Elisabetta;
... Yip, Terry Cheuk-Fung; + view all
(2025)
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurement.
Clinical and Molecular Hepatology
10.3350/cmh.2025.0888.
(In press).
|
|
Roberts, D;
Best, LM;
Freeman, SC;
Sutton, AJ;
Cooper, NJ;
Arunan, S;
Begum, T;
... Gurusamy, KS; + view all
(2021)
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 4
, Article CD013155. 10.1002/14651858.CD013155.pub2.
|
|
Roberts, D;
Tsochatzis, E;
Gurusamy, KS;
(2018)
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: A network meta-analysis.
Cochrane Database of Systematic Reviews
, 2018
(10)
10.1002/14651858.CD013155.
|
|
Roccarina, D;
Best, LM;
Freeman, SC;
Roberts, D;
Cooper, NJ;
Sutton, AJ;
Benmassaoud, A;
... Gurusamy, KS; + view all
(2021)
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 4
, Article CD013121. 10.1002/14651858.CD013121.pub2.
|
|
Roccarina, D;
Iogna Prat, L;
Pallini, G;
Guerrero Misas, M;
Buzzetti, E;
Saffioti, F;
Aricò, FM;
... Tsochatzis, EA; + view all
(2022)
Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease.
Liver International
, 42
(10)
pp. 2195-2203.
10.1111/liv.15297.
|
|
Roccarina, D;
Majumdar, A;
Thorburn, D;
Davidson, BR;
Tsochatzis, E;
Gurusamy, KS;
(2017)
Management of people with intermediate-stage hepatocellular carcinoma.
Cochrane Database of Systematic Reviews
, 2017
(3)
, Article CD011649. 10.1002/14651858.CD011649.pub2.
|
|
Roccarina, D;
Rosselli, M;
Genesca, J;
Tsochatzis, EA;
(2018)
Elastography methods for the non-invasive assessment of portal hypertension.
Expert Review of Gastroenterology & Hepatology
, 12
(2)
pp. 155-164.
10.1080/17474124.2017.1374852.
|
|
Rodrigues, SG;
Abraldes, JG;
Tsochatzis, E;
Bosch, J;
Berzigotti, A;
(2021)
Royal Free Hospital-estimated glomerular filtration rate for prognostic stratification of first acute kidney injury in cirrhosis.
Liver International
, 41
(4)
pp. 819-827.
10.1111/liv.14765.
|
|
Rodriguez-Peralvarez, Manuel L;
Majumdar, Avik;
Tsochatzis, Emmanuel;
(2025)
Letter to the Editor: Time for validating GEMA-Na in the United States for liver transplant waiting list prioritization.
Liver Transplantation
, 31
(2)
E9-E10.
10.1097/LVT.0000000000000483.
|
|
Rodríguez-Perálvarez, Manuel Luis;
Gómez-Orellana, Antonio Manuel;
Majumdar, Avik;
Bailey, Michael;
McCaughan, Geoffrey W;
Gow, Paul;
Guerrero, Marta;
... Tsochatzis, Emmanuel A; + view all
(2022)
Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
The Lancet Gastroenterology & Hepatology
10.1016/S2468-1253(22)00354-5.
(In press).
|
|
Rodríguez-Perálvarez, Manuel Luis;
Gómez-Orellana, Antonio Manuel;
Tsochatzis, Emmanuel A;
(2025)
GEMA-AI: artificial intelligence for a more rational and equitable access to liver transplantation.
Clinical Gastroenterology and Hepatology
10.1016/j.cgh.2025.06.016.
(In press).
|
|
Rodríguez-Perálvarez, Manuel Luis;
Majumdar, Avik;
Tsochatzis, Emmanuel;
(2025)
Sex disparities in accessing liver transplantation: biased renal function assessment is the main culprit.
American Journal of Transplantation
, 25
(1)
pp. 219-220.
10.1016/j.ajt.2024.08.009.
|
|
Rodríguez-Perálvarez, M;
De la Mata, M;
Tsochatzis, E;
(2020)
Tacrolimus trough concentrations after liver transplantation: back to the future.
[Letter].
Transplantation
, 104
(4)
e114.
10.1097/TP.0000000000003086.
|
|
Rodríguez-Perálvarez, M;
De Luca, L;
Crespo, G;
Rubin, Á;
Marín, S;
Benlloch, S;
Colmenero, J;
... De la Mata, M; + view all
(2017)
An objective definition for clinical suspicion of T-cell mediated rejection after liver transplantation.
Clinical Transplantation
, 31
(7)
10.1111/ctr.13005.
|
|
Rodríguez-Perálvarez, M;
Guerrero, M;
De Luca, L;
Gros, B;
Thorburn, D;
Patch, D;
Aumente, MD;
... De la Mata, M; + view all
(2019)
Area under trough concentrations of tacrolimus as a predictor of progressive renal impairment after liver transplantation.
Transplantation
, 103
(12)
pp. 2539-2548.
10.1097/TP.0000000000002760.
|
|
Rodríguez-Perálvarez, M;
Guerrero-Misas, M;
Thorburn, D;
Davidson, BR;
Tsochatzis, E;
Gurusamy, KS;
(2017)
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
Cochrane Database of Systematic Reviews
, 3
, Article CD011639. 10.1002/14651858.CD011639.pub2.
|
|
Rodríguez-Perálvarez, M;
Rico-Juri, JM;
Tsochatzis, E;
Burra, P;
De la Mata, M;
Lerut, J;
(2016)
Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.
Transplant International
, 29
(9)
pp. 961-973.
10.1111/tri.12737.
|
|
Rompianesi, G;
Ravikumar, R;
Jose, S;
Allison, M;
Athale, A;
Creamer, F;
Gunson, B;
... Tsochatzis, E; + view all
(2019)
Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients.
Liver International
, 39
(2)
pp. 353-360.
10.1111/liv.13947.
|
|
Ryan, JD;
Tsochatzis, EA;
(2017)
Rifaximin treatment for encephalopathy reduces hospital resource use: Real-world data don't fail to IMPRESS.
[Editorial comment].
Frontline Gastroenterology
, 8
(4)
pp. 230-231.
10.1136/flgastro-2017-100852.
|
|
Ryan, JD;
Tsochatzis, EA;
(2017)
MRE in NAFLD: Promising but Further Validation is Required.
Annals of Hepatology
, 16
(3)
pp. 331-332.
10.5604/16652681.1235474.
|
|
|
Saffioti, F;
Gurusamy, KS;
Eusebi, LH;
Tsochatzis, E;
Davidson, BR;
Thorburn, D;
(2017)
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Cochrane Databse of Systematic Reviews
, 3
, Article CD011648. 10.1002/14651858.CD011648.pub2.
|
|
Saffioti, F;
Gurusamy, KS;
Hawkins, N;
Toon, CD;
Tsochatzis, E;
Davidson, BR;
Thorburn, D;
(2017)
Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.
Cochrane Databse of Systematic Reviews
, 3
, Article CD011343. 10.1002/14651858.CD011343.pub2.
|
|
Schattenberg, JM;
Lazarus, JV;
Newsome, PN;
Serfaty, L;
Aghemo, A;
Augustin, S;
Tsochatzis, E;
... Ratziu, V; + view all
(2021)
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
Liver International
, 41
(6)
pp. 1227-1242.
10.1111/liv.14825.
|
|
Sebastiani, Giada;
Milic, Jovana;
Kablawi, Dana;
Gioe', Claudia;
Al Hinai, Al Shaima;
Lebouché, Bertrand;
Tsochatzis, Emmanuel;
... Guaraldi, Giovanni; + view all
(2023)
Fibroscan-aspartate aminotransferase (FAST) score predicts liver-related outcomes, but not extra-hepatic events, in a multicenter cohort of people with HIV.
Clinical Infectious Diseases
, 77
(3)
pp. 396-404.
10.1093/cid/ciad203.
|
|
Sebastiani, Giada;
Milic, Jovana;
Tsochatzis, Emmanuel A;
Marzolini, Catia;
Betel, Michael;
Bhagani, Sanjay;
Morse, Caryn G;
... Steatohepatitis in HIV Emerging Research (SHIVER), Network; + view all
(2023)
Letter to the editor: People living with HIV and NAFLD: A population left behind in the global effort for liver fibrosis screening?
Hepatology
, 75
(5)
E87-E88.
10.1097/HEP.0000000000000465.
|
|
Semmler, Georg;
Lens, Sabela;
Meyer, Elias L;
Baiges, Anna;
Alvarado-Tapias, Edilmar;
Llop, Elba;
Tellez, Luis;
... A study by the Baveno Cooperation: an EASL consortium; + view all
(2022)
Non-invasive tests for clinically significant portal hypertension after HCV cure.
Journal of Hepatology
, 77
(6)
pp. 1573-1585.
10.1016/j.jhep.2022.08.025.
|
|
Serra-Burriel, M;
Juanola, A;
Serra-Burriel, F;
Thiele, M;
Graupera, I;
Pose, E;
Pera, G;
... Laserna-Jiménez, C; + view all
(2023)
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
The Lancet
, 402
(10406)
pp. 988-996.
10.1016/S0140-6736(23)01174-1.
|
|
Sheridan, DA;
Aithal, G;
Alazawi, W;
Allison, M;
Anstee, Q;
Cobbold, J;
Khan, S;
... Tsochatzis, E; + view all
(2017)
Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey.
Frontline Gastroenterol
, 8
(4)
pp. 252-259.
10.1136/flgastro-2017-100806.
|
|
Shi, Yu;
Kim, Seung Up;
Cheuk-Fung Yip, Terry;
Tsochatzis, Emmanuel;
Petta, Salvatore;
Nakajima, Atsushi;
Hagström, Hannes;
... VCTE-Prognosis Study Group; + view all
(2025)
Effect of antidiabetic drug classes on the risk of liver-related events in individuals with T2D and MASLD.
Clinical Gastroenterology and Hepatology
10.1016/j.cgh.2025.06.001.
(In press).
|
|
Shi, Yu;
Zhou, Ruoqi;
Kim, Seung Up;
Yip, Terry Cheuk-Fung;
Tsochatzis, Emmanuel;
Petta, Salvatore;
Nakajima, Atsushi;
... VCTE-Prognosis Study Group; + view all
(2025)
Association between longitudinal weight change and clinical outcome in individuals with MASLD.
Hepatology
10.1097/HEP.0000000000001557.
|
|
Short, Emma;
Calimport, Stuart;
Bentley, Barry;
(2025)
Defining an ageing-related pathology, disease or syndrome: International Consensus Statement.
GeroScience
, 47
(2)
pp. 1713-1720.
10.1007/s11357-024-01315-9.
|
|
|
Shribman, S;
Bocchetta, M;
Sudre, CH;
Acosta-Cabronero, J;
Burrows, M;
Cook, P;
Thomas, DL;
... Warner, TT; + view all
(2021)
Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study.
Brain
10.1093/brain/awab274.
(In press).
|
|
|
Shribman, S;
Heller, C;
Burrows, M;
Heslegrave, A;
Swift, I;
Foiani, MS;
Gillett, GT;
... Warner, TT; + view all
(2020)
Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
Movement Disorders
10.1002/mds.28333.
(In press).
|
|
|
Simón-Talero, M;
Roccarina, D;
Martínez, J;
Lampichler, K;
Baiges, A;
Low, G;
Llop, E;
... Botella, ER; + view all
(2018)
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
Gastroenterology
, 154
(6)
1694-1705.e4.
10.1053/j.gastro.2018.01.028.
|
|
Socha, Piotr;
Janczyk, Wojciech;
Zanetto, Alberto;
Burra, Patrizia;
Czlonkowska, Anna;
Debray, Dominique;
Ferenci, Peter;
... Tsochatzis, Emmanuel; + view all
(2025)
EASL-ERN Clinical Practice Guidelines on Wilson's disease.
Journal of Hepatology
, 82
(4)
pp. 690-728.
10.1016/j.jhep.2024.11.007.
|
|
Srivastava, A;
Gailer, R;
Tanwar, S;
Trembling, P;
Parkes, J;
Rodger, A;
Suri, D;
... Rosenberg, W; + view all
(2019)
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.
Journal of Hepatology
10.1016/j.jhep.2019.03.033.
(In press).
|
|
|
Srivastava, A;
Jong, S;
Gola, A;
Gailer, R;
Morgan, S;
Sennett, K;
Tanwar, S;
... Rosenberg, W; + view all
(2019)
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease.
BMC Gastroenterology
, 19
(1)
, Article 122. 10.1186/s12876-019-1039-4.
|
|
|
Stasi, C;
Tsochatzis, EA;
Hall, A;
Rosenberg, W;
Milani, S;
Dhillon, AP;
Pinzani, M;
(2019)
Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease.
Digestive and Liver Disease
, 51
(7)
pp. 1001-1007.
10.1016/j.dld.2018.12.005.
|
|
Tai, D;
Dhar, A;
Yusuf, A;
Marshall, A;
O'Beirne, J;
Patch, D;
Tsochatzis, E;
... Westbrook, RH; + view all
(2018)
The Royal Free Hospital 'hub-and-spoke network model' delivers effective care and increased access to liver transplantation.
Public Health
, 154
pp. 164-171.
10.1016/j.puhe.2017.10.012.
|
|
Tampaki, Maria;
Tsochatzis, Emmanouil;
Lekakis, Vasileios;
Cholongitas, Evangelos;
(2025)
Prevalence, characteristics and outcomes of patients with metabolic and alcohol related/associated liver disease (MetALD): a systematic review and meta-analysis.
Metabolism
, 163
, Article 156101. 10.1016/j.metabol.2024.156101.
|
|
Tavabie, OD;
Enever, Y;
Green, D;
Crisp, H;
Tsochatzis, E;
Gander, A;
Mansour, D;
... Mehta, G; + view all
(2024)
From O'Shaughnessy to opportunity: Innovating Hepatology Trials in the UK.
Frontline Gastroenterology
10.1136/flgastro-2024-102710.
|
|
Thanapirom, K;
Tsochatzis, EA;
(2019)
Non-alcoholic fatty liver disease (NAFLD) and the quest for effective treatments.
Hepatobiliary Surgery and Nutrition
, 8
(1)
pp. 77-79.
10.21037/hbsn.2018.11.06.
|
|
|
Tripathi, D;
Stanley, AJ;
Hayes, PC;
Travis, S;
Armstrong, MJ;
Tsochatzis, EA;
Rowe, IA;
... Patch, D; + view all
(2020)
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension.
Gut
10.1136/gutjnl-2019-320221.
(In press).
|
|
|
Tsochatzis, EA;
(2022)
Natural history of NAFLD: knowns and unknowns.
Nature Reviews Gastroenterology & Hepatology
, 19
pp. 151-152.
10.1038/s41575-021-00565-8.
|
|
Tsochatzis, EA;
Verbeek, J;
(2022)
Editorial overview: The treatment of liver diseases in 2020-2030.
Current Opinion in Pharmacology
, 62
pp. 1-3.
10.1016/j.coph.2021.10.007.
|
|
Tsochatzis, Emmanuel A;
(2023)
Screening for liver fibrosis – sequential non-invasive testing works best.
Journal of Hepatology
, 79
(2)
pp. 263-265.
10.1016/j.jhep.2023.05.024.
|
|
Tsochatzis, Emmanuel A;
(2023)
EASL Recognition Award Recipient 2023: Prof. George Papatheodoridis.
Journal of Hepatology
, 79
(1)
pp. 8-9.
10.1016/j.jhep.2023.03.035.
|
|
Tsochatzis, Emmanuel A;
(2022)
Aldafermin in non-alcoholic steatohepatitis: a cautionary tale for trial design.
The Lancet Gastroenterology and Hepatology
, 7
(7)
pp. 586-587.
10.1016/S2468-1253(22)00049-8.
|
|
Tsochatzis, Emmanuel A;
Noureddin, Mazen;
(2025)
Combination Treatment in MASLD: The Next Frontier.
Clinical Gastroenterology and Hepatology
, 23
(1)
pp. 31-32.
10.1016/j.cgh.2024.05.021.
|
|
Tsochatzis, Emmanuel A;
Valenti, Luca;
Thiele, Maja;
Péloquin, Sophie;
Lazure, Patrice;
Masson, Mounia Heddad;
Allen, Alina M;
... Murray, Suzanne; + view all
(2024)
Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers.
Liver International
, 44
(8)
pp. 1990-2001.
10.1111/liv.15941.
|
|
Tsochatzis, Emmanuel A;
Watt, Kymberly D;
VanWagner, Lisa B;
Verna, Elizabeth C;
Berzigotti, Annalisa;
(2023)
Evaluation of recipients with significant comorbidity – Patients with cardiovascular disease.
Journal of Hepatology
, 78
(6)
pp. 1089-1104.
10.1016/j.jhep.2023.03.023.
|
|
Tsochatzis, E;
Coilly, A;
Nadalin, S;
Levistky, J;
Tokat, Y;
Ghobrial, M;
Klinck, J;
(2019)
International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation.
Transplantation
, 103
(1)
pp. 45-56.
10.1097/TP.0000000000002433.
|
|
Tsochatzis, EA;
Bosch, J;
(2017)
Statins in cirrhosis - ready for prime time.
[Editorial comment].
Hepatology
, 66
(3)
pp. 697-699.
10.1002/hep.29277.
|
|
Tsochatzis, EA;
Buzzetti, E;
Pinzani, M;
(2017)
Surrogate endpoints for clinical trials in non-alcoholic steatohepatitis.
Lancet Gastroenterology and Hepatology
, 2
(8)
pp. 549-550.
10.1016/S2468-1253(17)30184-X.
|
|
Tsochatzis, EA;
Crossan, C;
Longworth, L;
Gurusamy, K;
Rodriguez-Peralvarez, M;
Mantzoukis, K;
O'Brien, J;
... Burroughs, AK; + view all
(2014)
Cost-effectiveness of non-invasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C.
Hepatology
, 60
(3)
832- 843.
10.1002/hep.27296.
|
|
|
Tsochatzis, EA;
Gerbes, AL;
(2017)
Diagnosis and treatment of ascites.
Journal of Hepatology
, 67
(1)
pp. 184-185.
10.1016/j.jhep.2017.01.011.
|
|
Tsochatzis, EA;
Newsome, PN;
(2018)
Non-alcoholic fatty liver disease and the interface between primary and secondary care.
Lancet Gastroenterol Hepatol
, 3
(7)
pp. 509-517.
10.1016/S2468-1253(18)30077-3.
|
|
Tsochatzis, EA;
Papatheodoridis, GV;
(2016)
Case 21-2016: A man in an unresponsive state.
New England Journal of Medicine
, 375
(17)
p. 1697.
10.1056/NEJMc1610229.
|
|
Tsochatzis, EA;
Srivastava, A;
Rosenberg, W;
(2020)
Reply to: "FIB-4 cut off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease".
Journal of Hepatology
, 73
(1)
pp. 217-218.
10.1016/j.jhep.2020.02.016.
|
|
Tsompanaki, E;
Thanapirom, K;
Papatheodoridi, M;
Parikh, P;
Chotai de Lima, Y;
Tsochatzis, EA;
(2021)
Systematic Review and Meta-analysis: The Role of Diet in the Development of Nonalcoholic Fatty Liver Disease.
Clinical Gastroenterology and Hepatology
10.1016/j.cgh.2021.11.026.
(In press).
|
|
Valenti, L;
Pelusi, S;
Bianco, C;
Ceriotti, F;
Berzuini, A;
Iogna Prat, L;
Trotti, R;
... Prati, D; + view all
(2021)
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update.
Hepatology Communications
10.1002/hep4.1794.
(In press).
|
|
|
Valenti, Luca;
Corradini, Elena;
Adams, Leon A;
Aigner, Elmar;
Alqahtani, Saleh;
Arrese, Marco;
Bardou-Jacquet, Edouard;
... Zoller, Heinz; + view all
(2023)
Consensus Statement on the definition and classification of metabolic hyperferritinaemia.
Nature Reviews Endocrinology
, 19
pp. 299-310.
10.1038/s41574-023-00807-6.
|
|
Van Melkebeke, L;
Korf, H;
Tsochatzis, EA;
van der Merwe, S;
Nevens, F;
Verbeek, J;
(2021)
Treatment of severe alcoholic hepatitis: A systematic review.
Current Opinion in Pharmacology
, 60
pp. 91-101.
10.1016/j.coph.2021.06.011.
|
|
Vidal-González, J;
Martínez, J;
Mulay, A;
López, M;
Baiges, A;
Elmahdy, A;
Lampichler, K;
... Genescà, J; + view all
(2024)
Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis.
JHEP Reports
, 6
(2)
, Article 100977. 10.1016/j.jhepr.2023.100977.
|
|
Younossi, Zobair M;
de Avila, Leyla;
Petta, Salvatore;
Hagström, Hannes;
Kim, Seung Up;
Nakajima, Atsushi;
Crespo, Javier;
... Global NASH/MASH Council (GNC); + view all
(2025)
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.
Hepatology
10.1097/HEP.0000000000001617.
(In press).
|
|
Younossi, Zobair M;
de Avila, Leyla;
Petta, Salvatore;
Hagström, Hannes;
Kim, Seung Up;
Nakajima, Atsushi;
Crespo, Javier;
... Global NASH/MASH Council (GNC); + view all
(2025)
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study.
Hepatology
10.1097/HEP.0000000000001564.
(In press).
|
|
Younossi, Zobair M;
Wong, Vincent Wai-Sun;
Tsochatzis, Emmanuel A;
Castera, Laurent;
Betel, Michael;
Henry, Linda;
Sagi, Shira Zelber;
(2025)
Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health and Personalised Care.
Liver International
, 45
(10)
, Article e70311. 10.1111/liv.70311.
|
|
Younossi, Zobair M;
Zelber-Sagi, Shira;
Lazarus, Jeffrey V;
Wong, Vincent Wai-Sun;
Yilmaz, Yusuf;
Duseja, Ajay;
Eguchi, Yuichiro;
... Alqahtani, Saleh A; + view all
(2025)
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.
Gastroenterology
, 169
(5)
1017-1032.e2.
10.1053/j.gastro.2025.02.044.
|
|
Zakeri, N;
Tsochatzis, EA;
(2018)
Steatosis affects the sensitivity but not the specificity of non-invasive fibrosis tests in non-alcoholic fatty liver disease - implications for screening strategies.
[Editorial comment].
Liver International
, 38
(2)
pp. 224-226.
10.1111/liv.13602.
|
|
Zakeri, N;
Tsochatzis, EA;
(2017)
Bleeding Risk with Invasive Procedures in Patients with Cirrhosis and Coagulopathy.
Current Gastroenterology Reports
, 19
(9)
, Article 45. 10.1007/s11894-017-0585-6.
|
|
Zhou, XD;
Li, YT;
Kim, SU;
Yip, TCF;
Petta, S;
Nakajima, A;
Tsochatzis, E;
... Calleja, JL; + view all
(2025)
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD.
Clinical Gastroenterology and Hepatology
10.1016/j.cgh.2025.07.011.
(In press).
|
|
Zhou, Xiao-Dong;
Chen, Qin-Fen;
Kim, Seung Up;
Cheuk-Fung Yip, Terry;
Petta, Salvatore;
Nakajima, Atsushi;
Tsochatzis, Emmanuel;
... Zheng, Ming-Hua; + view all
(2025)
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD.
Clinical Gastroenterology and Hepatology
S1542-3565(25)00867.
10.1016/j.cgh.2025.10.003.
(In press).
|
|
Zhou, Xiao-Dong;
Kim, Seung Up;
Yip, Terry Cheuk-Fung;
Petta, Salvatore;
Nakajima, Atsushi;
Tsochatzis, Emmanuel;
Boursier, Jerome;
... Zheng, Ming-Hua; + view all
(2024)
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.
Gut
10.1136/gutjnl-2024-333074.
(In press).
|
|
Zhou, Xiao-Dong;
Lian, Li-You;
Chen, Qin-Fen;
Kim, Seung Up;
Cheuk-Fung Yip, Terry;
Petta, Salvatore;
Nakajima, Atsushi;
... Paired Liver Biopsy Group; + view all
(2025)
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD.
Journal of Hepatology
10.1016/j.jhep.2025.08.017.
(In press).
|
|
Zoncapè, Mirko;
Liguori, Antonio;
Tsochatzis, Emmanuel A;
(2024)
Non-invasive testing and risk-stratification in patients with MASLD.
European Journal of Internal Medicine
, 122
pp. 11-19.
10.1016/j.ejim.2024.01.013.
|
|
Zoncape, Mirko;
Liguori, Antonio;
Tsochatzis, Emmanuel A;
(2022)
Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease.
Hepatobiliary Surgery and Nutrition
10.21037/hbsn-22-58.
(In press).
|
|
Zoncapè, Mirko;
Tsochatzis, Emmanuel A;
(2025)
Liver Fibrosis Testing in Patients With Type 2 Diabetes: The Time Is Now.
Diabetes Care
, 48
(6)
pp. 871-873.
10.2337/dci25-0008.
|
|
Zoncape, Mirko;
Tsochatzis, Emmanuel A;
(2025)
Reply to correspondence on "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis".
Clinical and Molecular Hepatology
, 31
(1)
e117-e118.
10.3350/cmh.2024.0994.
|
|
|
Zoncape, Mirko;
Tsochatzis, Emmanuel A;
(2025)
The use of transient elastography for predicting hepatocellular carcinoma in chronic hepatitis B patients: Editorial on "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis".
Clinical and Molecular Hepatology
, 31
(1)
pp. 268-274.
10.3350/cmh.2024.0817.
|
Proceedings paper
|
Eddowes, PJ;
Anstee, Q;
Guha, IN;
Sheridan, DA;
Tsochatzis, E;
Cobbold, J;
Allison, ME;
... Newsome, PN; + view all
(2016)
Novel Fibroscan-Based Score to Diagnose NASH and its severity in A Multi-centre UK Cohort of Patients with Suspected NAFLD.
In:
Hepatology: Special Issue: The 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016.
(pp. 540A-540A).
Wiley
|
|
Eddowes, PJ;
Anstee, Q;
Guha, IN;
Sheridan, DA;
Tsochatzis, E;
Cobbold, J;
Allison, ME;
... Newsome, P; + view all
(2016)
Staging fibrosis and excluding advanced fibrosis in patients with NAFLD: comparison of non-invasive markers in an interim analysis from a prospective multicentre study.
In:
Hepatology: Special Issue: The 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016.
(pp. 569A-570A).
Wiley
|
Conference item
|
Firl, D;
Sasaki, K;
Kimura, S;
Dumronggittigule, W;
Gorgen, A;
Lerut, J;
Rossi, M;
... Aucejo, F; + view all
(2018)
Improving Prognostication amongst Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: An International, 16-Center Study to Validate and Recalibrate HALTHCC.
Presented at: 2018 American Transplant Congress, Seattle, WA, USA.
(In press).
|
|
Lai, Q;
Cillo, U;
Iesari, S;
Finkenstedt, A;
Rossi, M;
Tsochatzis, E;
Otto, G;
... European Hepatocellular Cancer Liver Transplant Study Group, .; + view all
(2018)
Bridging therapies are not detrimental in patients with hepatocellular cancer waiting for liver transplant: A propensity score analysis.
Presented at: 51st Annual Meeting of the Italian Association for the Study of the Liver (A.I.S.F), Rome, Italy.
|
|
Majumdar, A;
Roccarina, D;
Thorburn, D;
Davidson, BR;
Tsochatzis, EA;
Gurusamy, KS;
(2017)
Management of people with early or very early stage hepatocellular carcinoma: an attempted network meta-analysis.
Presented at: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands.
|
|
Maurice, J;
Tsochatzis, E;
Nelson, M;
Kelleher, P;
Garvey, L;
Thursz, M;
Lemoine, M;
(2018)
Diagnostic accuracy of non-invasive markers of fibrosis in HIV mono-infected patients with histologically confirmed NAFLD.
Presented at: 4th Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), Edinburgh, UK.
|
|
Mcpherson, S;
Pais, R;
Valenti, L;
Schattenberg, JM;
Dufour, J-F;
Tsochatzis, E;
Francque, S;
... Anstee, Q; + view all
(2017)
Simple non-invasive fibrosis scores identify patients with nonalcoholic fatty liver disease who progress to advanced fibrosis/cirrhosis: evidence from a large cohort of patients with sequential liver biopsies.
Presented at: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands.
|
|
|
Mcpherson, S;
Pais, R;
Valenti, L;
Schattenberg, JM;
Dufour, J-F;
Tsochatzis, E;
Francque, S;
... Anstee, Q; + view all
(2017)
Further delineation of fibrosis progression in NAFLD: evidence from a large cohort of patients with sequential biopsies.
Presented at: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, The Netherlands.
|
|
Simon-Talero, M;
Roccarina, D;
Majumdar, A;
Tsochatzis, EA;
Martinez, J;
Picon, C;
Albillos, A;
... Genesca, J; + view all
(2017)
Portosystemic shunts in cirrhosis are associated to more complications and deteriorated quality of life: an international cohort study.
Presented at: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands.
|
|
Simon-Talero, M;
Roccarina, D;
Majumdar, A;
Tsochatzis, EA;
Martinez, J;
Picon, C;
Albillos, A;
... Genesca, J; + view all
(2017)
Portosystemic shunts in cirrhosis are associated to more complications and deteriorated quality of life. An international cohort study.
Presented at: 23rd National Congress of Digestive Diseases, Bologna, Italy.
|
|
Tsochatzis, E;
Hiriart, JB;
Lupsor-Platon, M;
Bronte, F;
Boursier, J;
Marra, F;
Payance, A;
... Pinzani, M; + view all
(2017)
Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease: an individual patient meta-analysis.
Presented at: International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands.
|
